$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent

Blood, v.96 no.10, 2000년, pp.3369 - 3373  

Singer, Sylvia T. (From the Department of Hematology) ,  Wu, Vivian (From the Department of Hematology) ,  Mignacca, Robert (From the Department of Hematology) ,  Kuypers, Frans A. (From the Department of Hematology) ,  Morel, Phyllis ,  Vichinsky, Elliott P.

Abstract AI-Helper 아이콘AI-Helper

The development of hemolytic alloantibodies and erythrocyte autoantibodies complicates transfusion therapy in thalassemia patients. The frequency, causes, and prevention of this phenomena among 64 transfused thalassemia patients (75% Asian) were evaluated. The effect of red blood cell (RBC) phenotyp...

참고문헌 (29)

  1. Scand J Haematol. Kruatrachue 25 259 1980 10.1111/j.1600-0609.1981.tb01398.x An association between thalassemia and autoimmune haemolytic anaemia (AIHA). 

  2. Acta Haematol. Argiolu 83 65 1990 10.1159/000205170 High-dose intravenous immunoglobulin in the management of autoimmune hemolytic anemia complicating thalassemia major. 

  3. Ann Hematol. Cianciulli 73 379 1996 10.1007/s002770050190 Radiotherapy combined with erythropoietin for the treatment of extramedullary hematopoiesis in an alloimmunized patient with thalassemia intermedia. 

  4. Transfusion. Ness 34 688 1990 10.1046/j.1537-2995.1990.30891020325.x The differentiation of delayed serologic and delayed hemolytic transfusion reaction: incidence, long term serologic findings, and clinical significance. 

  5. Transfusion. Ness 34 558 1994 10.1046/j.1537-2995.1994.34794330007.x To match or not to match: the question for chronically transfused patients with sickle cell anemia. 

  6. Transfusion. Fluit 30 532 1990 10.1046/j.1537-2995.1990.30690333485.x Incidence of red cell antibodies after multiple blood transfusion. 

  7. J Lab Clin Med. Kuypers 116 535 1990 Use of ektacytometry to determine red cell susceptibility to oxidative stress. 

  8. Blood. Waugh 79 1351 1992 10.1182/blood.V79.5.1351.1351 Rheologic properties of senescent erythrocytes: loss of surface area and volume with red blood cell age. 

  9. Vox Sang. Blumberg 47 205 1984 Should chronic transfusions be matched for antigens other than ABO and Rho(D)? 

  10. Vox Sang. Economidou 20 252 1971 10.1159/000466635 Frequency of antibodies to various antigenic determinants in polytransfused patients with homozygous thalassaemia in Greece. 

  11. Transfusion. Sirchia 25 110 1985 10.1046/j.1537-2995.1985.25285169198.x Red cell alloantibodies in thalassemia major: results of an Italian cooperative study. 

  12. Transfusion. Coles 21 462 1981 10.1046/j.1537-2995.1981.21481276005.x Alloimmunization in two multi-transfused patient populations. 

  13. Nouv Rev Fr Hematol. Hmida 36 363 1994 Red cell alloantibodies in patients with haemoglobinopathies. 

  14. Arch Pathol Lab Med. Walker 113 254 1989 Alloimmunization following blood transfusion. 

  15. Vox Sang. Michail-Merianou 52 95 1987 10.1159/000461619 Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes. 

  16. Vox Sang. Spanos 58 50 1990 Red cell alloantibodies in patients with thalassemia. 

  17. N Engl J Med. Vichinsky 322 1617 1990 10.1056/NEJM199006073222301 Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. 

  18. Vox Sang. Blajchman 74 315 1998 10.1111/j.1423-0410.1998.tb05437.x Immunomodulatory effects of allogenic blood transfusions: clinical manifestations and mechanisms. 

  19. Br J Haematol. Grady 59 713 1985 10.1111/j.1365-2141.1985.tb07367.x Disproportionate lymphoid cell subsets in thalassemia major: the relative contributions of transfusion and splenectomy. 

  20. Br J Haematol. Hodge 105 817 1999 10.1046/j.1365-2141.1999.01385.x Functional lymphocyte immunophenotypes observed in thalassemia and haemophilia patients receiving current blood product preparations. 

  21. Birth Defects Orig Artic Ser. Grady 23 587 1988 Transfusion-related immunologic abnormalities in β-thalassemia major. 

  22. Br J Haematol. Kapadia 45 405 1980 10.1111/j.1365-2141.1980.tb07161.x Lymphoid cell sets and serum immunoglobulins in patients with thalassemia intermedia: relationship to serum iron and splenectomy. 

  23. Blood. Ghio 93 1770 1999 10.1182/blood.V93.5.1770 Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. 

  24. Curr Opin Hematol. Sibinga 6 442 1999 10.1097/00062752-199911000-00016 Immune effects of blood transfusion. 

  25. Br J Haematol. Castellino 104 189 1999 10.1046/j.1365-2141.1999.01127.x Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. 

  26. Br J Haematol. Delamaire 80 91 1992 10.1111/j.1365-2141.1992.tb06405.x Is there a mechanical factor for haemolysis in patients with positive IgG-type direct antiglobulin test? 

  27. Blood Cells. Galili 14 205 1988 The natural anti-Gal antibody, the B-like antigen, and human red cell aging. 

  28. Br J Exp Path. Cox 60 466 1979 Impaired regulation of erythrocyte autoantibody production after splenectomy. 

  29. Blood. Rosse 76 1431 1990 10.1182/blood.V76.7.1431.1431 Transfusion and alloimmunization in sickle cell disease. 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로